Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4288784
Max Phase: Preclinical
Molecular Formula: C26H19N5O2
Molecular Weight: 433.47
Molecule Type: Small molecule
Associated Items:
ID: ALA4288784
Max Phase: Preclinical
Molecular Formula: C26H19N5O2
Molecular Weight: 433.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1nnn(CCn2c(-c3ccccc3)c(-c3ccccc3)oc2=O)c1-c1ccccc1
Standard InChI: InChI=1S/C26H19N5O2/c27-18-22-23(19-10-4-1-5-11-19)31(29-28-22)17-16-30-24(20-12-6-2-7-13-20)25(33-26(30)32)21-14-8-3-9-15-21/h1-15H,16-17H2
Standard InChI Key: ZBCXNQHQLMGSNQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 433.47 | Molecular Weight (Monoisotopic): 433.1539 | AlogP: 4.61 | #Rotatable Bonds: 6 |
Polar Surface Area: 89.64 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.48 | CX LogD: 4.48 |
Aromatic Rings: 5 | Heavy Atoms: 33 | QED Weighted: 0.39 | Np Likeness Score: -0.98 |
1. Ramírez-Villalva A, González-Calderón D, Rojas-García RI, González-Romero C, Tamaríz-Mascarúa J, Morales-Rodríguez M, Zavala-Segovia N, Fuentes-Benítes A.. (2017) Synthesis and antifungal activity of novel oxazolidin-2-one-linked 1,2,3-triazole derivatives., 8 (12): [PMID:30108741] [10.1039/C7MD00442G] |
Source(1):